Building a comprehensive cancer survivorship program

Tessa Flores¹, Kathryn M Glaser², Douglas McDaniel^2,3, Denise Rokitka³, Katharine A Amato^4,5 and Mary E Reid¹

¹Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA

²Department of Cancer Prevention and Populations Science, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA

³Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA

⁴Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA

⁵Department of Family Medicine, Primary Care Research Institute, University at Buffalo, Buffalo, NY 14260, USA

Abstract

There is a significant increase in the number of people surviving cancer as a result of improved detection and better treatments. In the United States (US) alone, these numbers are estimated to reach 20 million by 2026 [Miller et al (2016) CA Cancer J Clin 66(4) 271–289)]; [Bluethmann et al (2016) Cancer Epidemiol Biomarkers Prev 25(7) 1029–1036]. Living through cancer treatment represents a life-changing event, often including residual and long-term emotional, physical, psychological and spiritual sequelae. Survivorship programming must encompass the clinical management of medical issues, local support services for patients and their caregivers, protocols for communicating with community primary care providers (PCPs) and education for all clinicians in the survivorship continuum on the issues impacting survivors. This article will discuss a range of issues that should be addressed when developing a comprehensive, multi-disciplinary cancer survivorship care.

Keywords: cancer survivorship, integrative medicine, long-term survivors, quality of life, cancer continuum

Correspondence to: Dr Mary E Reid
Email: mary.reid@roswellpark.org

Published: 12/12/2019
Received: 23/07/2019

Publication costs for this article were supported by ecancer (UK Charity number 1176307).

Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction: survivorship trends and cancer sequelae

The emphasis on developing survivorship programs is driven by the increasing numbers of cancer survivors. It is estimated that 20 million cancer survivors will be living in the United States (US) by the year 2026 [1, 2]. Patients are living longer, even with residual disease, with cancers that were previously considered terminal. For long-term survivors (LTS), there are several organisations with some general guidelines outlining survivorship care: the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS). However, evidence-based guidelines are uncommon on how to best deliver these services for the detection of recurrent disease, management of symptoms resulting from treatment and support the emotional, physical, psychological and spiritual effects of cancer diagnoses and treatment. It is clear that this gap results in many unmet needs among LTS and their support systems [3, 4].

Survivorship care models

Individualising and personalising survivorship care to your patient population is a critical first step in meeting the needs of the survivor population. Assessments on needs should be completed by all members across the survivorship care continuum, including patients and caregivers, to identify gaps in care and services. In addition, institutional and community providers should be included to determine educational opportunities and support services should be identified. Input from multiple shareholders, including oncology teams and community providers, is necessary to change patterns of care to accommodate survivor needs.

Several models of survivorship care programs exist which embed survivorship care within cancer centres, although few show how survivorship care can integrate into independent community practices. Free-standing or matrix cancer centres routinely have survivorship programs that are either: 1) decentralised where survivorship care happens in the primary oncology clinics; 2) centralised where all survivors come to one clinic coordinating survivorship care and 3) or a mixed model [5–8]. The structure is dependent on the size and location of the cancer centre, the preferences of the oncology teams and the potential numbers of survivors that will require surveillance care at the institution.

The program at Roswell Park Comprehensive Cancer Center (Roswell) is a mixed model of survivorship care. As a small, urban, free-standing comprehensive cancer centre, most solid tumour survivors, particularly breast, gynaecologic (GYN), head and neck (H&N), lung and some gastrointestinal (GI) cancers, are eventually transferred to the Survivorship Program for long-term follow-up care. This transitions patients from congested clinics whose primary focus is on newly diagnosed patients and those undergoing active treatment to a patient-centred care model focused on rehabilitation and wellness. As a comprehensive cancer centre, we have designed the program to meet national standards and guidelines, including NCCN, ASCO, ACS and the Commission on Cancer (CoC) (see Table 1). As the program is integrated into standard oncology practice, representing a culture change, it is necessary to have strong support and commitment from leadership.

However, all oncology teams do not incorporate survivorship care in the same way. Some disease sites prefer to monitor survivors in the original oncology clinic. At Roswell, this is the case for the haematologic cancers (leukaemia, lymphoma, multiple myeloma and bone marrow transplant) as well as genitourinary (GU) cancers. In contrast, the breast and gynaecology programs have embraced the transfer to survivorship as part of the long-term care pathway.

There are two ways for survivors to access the Survivorship Center (SC) at Roswell. The first starts as a one-time consultation at the beginning of the post-treatment period, where they can be immediately immersed in an array of support services. The second is a transfer of care to survivorship for continued surveillance of their primary cancer(s), to monitor for residual effects of treatment, to restart preventive cancer screening and to re-establish the connection with the primary care provider (PCP). Frequency of surveillance visits is based on NCCN guidelines for their cancer type, the tumour staging and response to treatments.

Other survivorship care delivery models focus long-term care and surveillance of survivors in community settings, including community oncology and primary care practices. If community oncologists are connected to a larger cancer centre network, such as a satellite or affiliate site, survivorship care can be incorporated within the network, moving towards patient-centred and personalised survivorship care. The alternative is for the PCP to take full responsibility for survivorship care, including surveillance and symptom management. This model allows oncology centres to decompress their patient load, easier access for patients and better monitoring of non-cancer comorbidities.

Sharing care of patients

A cornerstone to quality survivorship care is establishing a strong relationship between the PCP, the oncology team, the survivorship team and the patient. When patients are initially diagnosed with cancer and are referred to oncologists, the PCP often plays a secondary role in patient care, more frequently than with other medical specialities where more of the care is shared with the PCP [9]. When cancer treatment is finished, re-engaging the PCP requires targeted communication. Transitioning survivorship care to the PCP can be complicated because PCPs do not necessarily incorporate the survivorship guidelines into a standard of care. In addition, there is little guidance from experts, like oncologists, and most electronic health record systems do not support cancer-specific guidelines [9].

Table 1. Examples of websites of survivorship treatment guidelines and comprehensive programs.

The survivorship care plan (SCP) is a means of communication that promotes a shared-care coordination model [9, 10]. As research on SCPs has shown, the plan alone does not relieve stress for survivors [19, 20]. However, it provides information to the PCP on treatment received, potential long-term sequelae, and provides a road map of survivorship care that improves their level of confidence in managing survivors. Although early research on SCPs was not done in the context of offering quality survivorship care, the document itself may positively impact patients if they receive the services and support recommended in the SCP. At Roswell, our providers have generated 3,600 care plans and effectively use the SCP to communicate follow-up plans with their patients. The SCP standard should highlight the cancer surveillance schedule, support service referrals, cancer screening recommendations, potential long-term complications related to the treatment and recommendations regarding monitoring of long-term complications to the PCP [11].

In addition, the SCP should also specify what testing should be done and who should be doing it, to avoid duplication of effort. For example, for breast cancer survivors on long-term hormonal therapy, lipid profiles should be done by the PCP since they are considering other cardiovascular risks and conditions not related to cancer. At Roswell, our patient navigator ensures that the correct PCP is recorded in the electronic medical record, which in turn guarantees that the correct PCP receives correspondence and the personalised SCP for each LTS. The patient navigator also facilitates a new patient appointment with a PCP if needed to ensure continuity of care.

However, there is a growing literature supporting that PCPs are not always prepared to address the needs of cancer survivors [8, 12–15]. There is also evidence that the relationship between patients and their PCPs is neglected during cancer treatment and, thus, the PCP is not always aware of the status of their patients as they complete treatment. The Institute of Medicine’s 2006 seminal report, which continues to be relevant today, highlighted how the transition of care from oncology to primary care is often fragmented and lacks coordination [8, 12].

PCPs often do not have a complete treatment summary from oncologists, which also limits their ability to monitor side effects from treatment. Table 2 summarises the most common side effects of cancer treatment. As a result, many cancer survivors feel uncertain about their care once they are in transition from oncologists to PCPs [16]. In addition, PCPs may not be up to date on the latest treatments for side effects or the current trends in surveillance and survivorship guidelines. It is essential that the oncology or survivorship clinical teams communicate clearly with the PCPs on the surveillance plans for survivors re-entering their PCP care. In addition, educational programs on survivorship can provide PCPs with the skills to follow surveillance guidelines as well as to detect and identify any new cancers.

The structure of survivorship care

There are many options for structuring survivorship care. Based on our experience in developing a new program, we considered several goals of care. It is important to provide patients and their caregivers with patient-oriented care. Each visit should include a comprehensive physical and psychological assessment. Access must be provided to support services for both patients and caregivers. It is critical to individualise survivorship care with the use of care plans (SCP) that provide a roadmap for future care and services to facilitate communication between the oncology teams and community-based PCPs. It is also important to maximise the level of health and wellness for every survivor and their support network through education, wellness activities and integrative medicine.

Table 2. List of treatment sequelae for cancer survivors.

Roswell’s SC opened in January 2017 for any patient who would benefit from survivorship and supportive care services. Clinical assessments are supplemented with appropriate support services utilising specialised resources (nutrition, rehabilitation, acupuncture, social work, psychology and wellness programs) in order to improve the quality of life (QoL) for survivors, caregivers and their support networks. This includes actively coordinating surveillance and follow-up care with PCPs and other community providers. The initial target population was primarily cancer survivors who had completed treatment and were outside a surveillance window that could be permanently transferred to the SC for long-term follow-up care. Now patients can be referred to survivorship upon completion of treatment to receive an SCP and be introduced to the survivorship care model, start rehabilitation and wellness, and return to the oncology clinic for follow-up until the oncologist transfers them to the SC for long-term survivorship care.

The survivorship clinical team consists of a medical director who serves as an oncogeneralist (board-certified in internal medicine and paediatrics) for the adult patients, a paediatric oncologist for the paediatric survivors under 40 years and young adult survivors (under 40 years at the time of diagnosis), a family practitioner for paediatric survivors over the age of 40, an oncology trained nurse practitioner (NP), clinical nurse care coordinators and a patient care navigator. Scheduling templates were adjusted according to volumes to make sure that we were not overstaffing the clinic. As of July 2019, 2,436, survivors have been seen in the clinic. The majority of these cancer survivors were breast (54%), paediatric (20%), GYN (17%), as well as adolescent and young adult (3%) cancer survivors. Other cancer disease sites (6%) that have transferred care for the LTS are gastroenterology (GI), thoracic, GU, and head and neck (H&N) cancers.

Our survivorship team also includes a nutritionist, social workers, psychologists and integrative medicine providers. The team monitors for recurrence of cancer and new cancers, reviews the recent medical history and completes a thorough physical examination. In addition, the team identifies and manages the side effects of cancer, providing counselling on healthy living habits, such as diet and exercise, and referrals to screening tests for other cancers, and connects patients with PCPs and/or outside experts.

Assessment tools: the quality of life questionnaire

The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire – Core 30 (QLQ) is a widely used QoL questionnaire in cancer care [15, 17]. At every routine surveillance visit, the cancer survivor completes this questionnaire prior to seeing the provider. The EORTC QLQ assesses five domains including physical function, emotional function, role function, fatigue, pain and global function. These domains are summarised, and clinical thresholds prompt further inquiry and possible referrals based on four domains (physical function, emotional function, fatigue and pain) [7].

Depending on their EORTC QLQ scores, LTS are assessed and referred to physical therapy, occupational therapy, bioenergy therapies (acupuncture, Reiki) and psychosocial counselling. As of December 2018, 1,160 LTS completed the EORTC QLQ at least once and, when combined with tumour registry information, allows us to explore trends from the QoL assessments to better understand the needs of our patient population and adjust the services available to them.

Identifying support services

Whether survivorship care happens within an institution or in the community, it is critical to identify an array of support services that can address the needs of survivors in advance of opening the program. At Roswell, most of these services were already available but not organised around survivorship care. Coordinating these various services required several meetings to educate the team on their role in care and to work out the pathways for referrals. In a community-based care setting, this process is comparable. Wherever the services are based, there is some vetting and training required to make sure that the various services understand the impact of cancer and the specific needs of cancer survivors. For example, physical therapists must be able to set appropriate performance and training standards to accommodate physical limitation from cancer surgeries or other therapies.

In November 2015, Roswell’s Marketing and Communications Department mailed 35,420 letters to all current living patients and invited them to participate in an online survey to help develop the survivorship program. Patients were informed that the purpose of the survey was to gather information on interest in specific programs and their response would influence the services offered to Roswell Park survivors through the survivorship program. A total of 1,054 surveys were completed, resulting in a 3% response rate. Table 3 summarises the 10 most frequently requested support services by survey 3 respondents. This survey laid the foundation of the support services offered to LTS through the program.

The clinical space that houses both the Survivorship and Palliative Medicine Programs is a central hub for these support services. Psychiatry, psychology, social work, nutrition, acupuncture and biofield therapies are physically housed in the centre. Other support and wellness programs, such as physical rehabilitation, yoga, massage, meditation, support groups and education groups, are offered throughout the cancer centre. See the summary of the available support services in Table 4. All these support services are offered to LTS and caregivers. To address the spiritual concerns of our LTS, we refer them to our pastoral care program within the cancer centre which includes a chapel open to our patients and families and. This is a multi-denominational program that services our inpatient units, but appointments can be made for our LTS during their clinical visits. This service has provided special activities for survivors, such as Yoga and storytelling, which are aimed at providing a venue to discuss spiritual issues. To expand specialised programs to meet the ongoing needs of LTS, Roswell is now developing a sexual health clinic. This clinic will have GU and GYN-trained surgeons to address sexual dysfunction issues and an NP and psychologist to provide sexual health therapy and support for LTS.

Screening for other primary cancers

In addition to continued surveillance of their original cancer as dictated by NCCN guidelines, LTS need standard cancer screening. About 80% of newly diagnosed cancers are found in individuals with a prior history of cancer [18]. This makes surveillance for a second primary cancer a requirement for all survivorship programs. Individual patient needs for breast, colon, cervical, oral, prostate and lung cancer should be evaluated. The survivorship program shares a staff and physical space with the cancer screening program, resulting in a seamless process for facilitating guideline-driven cancer screening. In a community setting, the PCP should be aware of current screening guidelines and be encouraged to review adherence annually.

Table 3. The top ten support services requested by cancer survivors.

Table 4. Array of support services available to cancer survivors.

Importantly, cancer screening is scheduled at the convenience of the patient. We have partnered with two community gastroenterology practices to provide screening colonoscopy. Our patients go directly to the colonoscopy procedure at a location, streamlining the process and making it more convenient. We can also arrange mammograms on the same day as the survivorship appointment. If LTS meet the criteria for lung cancer screening, we order the first initial low-dose CT and then navigate them to the High Risk Lung Cancer Screening Clinic at Roswell for further evaluation and management. We also perform Pap tests for cervical cancer screening and digital rectal exams for early prostate detection, and then navigate patients back to community providers for further follow-up. Finally, the genetic testing service is embedded in the cancer screening program. This facilitates genetic testing, including the rescreening of patients who had BRCA1/2 prior to 2012 according to new standards and guidelines.

Refining survivorship care

As standards for survivorship care are refined and expanded throughout the US, there are many lessons that can be learned from the innovative approaches developed in England and Ireland [3, 4]. The published proceedings from ASCO and the ACS described the collaborative efforts led by the National Cancer Survivorship Initiative (NCSI) and National Health Service (NHS) to initiate change in post-treatment recovery care and the risk stratification of survivors [4]. The program to develop personalised care pathways rests on four basic elements: 1) a comprehensive assessment of the survivor; 2) generating and sharing a treatment summary with patients and community-based PCPs; 3) reviewing the summary with the patient and 4) supporting community events to inform survivors of coping strategies and promoting wellness. In conjunction with this strategy, the NCSI stratified cancer survivors into three risk categories (low, moderate and high) based on their cancer, their treatment and response and the degree of exposure to toxicity causing regimens. As outlined by Alfano et al [4], the intensity of surveillance of survivors by risk level is both a sound concept and more cost-effective.

There are several sequelae that can impact LTS QoL over time and require vigilant surveillance and coordination of multiple services. Cardiotoxicities, for example, can appear decades after the exposure to cardiotoxic therapies. Many cancer treatment therapies, with the exception of many surgeries, can impact post-treatment fertility. Symptoms such as xerostomia (dry mouth resulting from reduced or absent saliva flow) can occur in head and neck survivors 5–10 years post-treatment. It is important that survivorship programs are aware of the potential long-term effects of cancer treatment and develop collaborations with specialists prepared to address these issues. Oncocardiologists, endocrinologists, dentists and fertility specialists are examples of the more common specialists who can contribute to providing coordinated survivorship care. These providers can work hand-in-hand with the survivorship team and PCPs to provide comprehensive care. It is imperative that all members of the survivorship care team, regardless of where they practice, be aware of the early signs of these sequelae.

The role of survivorship research

Clinical research is the key to our ability to close the gaps in understanding the best way to treat survivors and improve survivorship care. Clinical programs must be structured to seamlessly incorporate clinical research. It is critical that an evidence base can be developed to guide the development of effective health care models, risk models of survivor co-morbidities and mortality, optimal times to intervene with the best treatments, to the longest overall survival and highest QoL for survivors. Finally, research must clarify the capacity of LTS to change their behaviours, both from a disease prevention and a health promotion standpoint [11]. While survivorship programs embedded in cancer centres can offer direct access to a large population of survivors, survivorship research must also be embedded in community settings.

Summary

With the increasing number of people surviving cancer, it is important to plan for the long-term care and symptom management needs of this population. In this decade, survivorship care development must 1) account for the acuity of survivors; 2) identify the levels of risks of persistent or severe toxicities; 3) designate who will provide survivorship care, including the management of unique medical and psychological issues resulting from cancer treatment; and 4) determine the availability of the supportive services needed by survivors and their caregivers. Ultimately, research must clarify both the best health care models for caring for survivors and the optimal regimes that will result in the highest QoL for this growing population.

Conflicts of interest

There are no conflicts of interest to declare for any of these authors relative to this work.

Funding

This work was supported by Roswell Park Comprehensive Cancer Center and NCI grant P30CS016056. The Integrative Medicine program is supported by the Roswell Park Alliance Foundation.

Authors’ contributions

Tessa Flores, Kathryn M Glaser and Mary E Reid contributed equally to the writing of this paper. Douglas McDaniel, Denise Rokitka, and Katharine A Amato reviewed and contributed to the editing of the text.

Acknowledgments

This work was supported by Roswell Park Comprehensive Cancer Center and NCI grant P30CS016056. The Integrative Medicine Program and the Nutritionist for Survivorship are supported by the Roswell Park Alliance Foundation. The authors wish to acknowledge and thank the Roswell Park Reiki volunteers and all other volunteers who donated their time in the Supportive Care Clinic.

References

1. Miller KD, Siegel RL, and Lin CC, et al (2016) Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66(4) 271–289 https://doi.org/10.3322/caac.21349 PMID: 27253694

2. Bluethmann SM, Mariotto AB, and Rowland JH (2016) Anticipating the ‘silver tsunami’: prevalence trajectories and comorbidity burden among older cancer survivors in the United States Cancer Epidemiol Biomarkers Prev 25(7) 1029–1036 https://doi.org/10.1158/1055-9965.EPI-16-0133 PMID: 27371756 PMCID: 4933329

3. Alfano CM, Jefford M, and Maher J, et al (2019) Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia Am Soc Clin Oncol Educ Book 39 625–639 https://doi.org/10.1200/EDBK_238267 PMID: 31099658

4. Alfano CM, Mayer DK, and Bhatia S, et al (2019) Implementing personalized pathways for cancer follow-up care in the United States:Pproceedings from an American Cancer Society-American Society of Clinical Oncology summit CA Cancer J Clin 69(3) 234–247 https://doi.org/10.3322/caac.21558 PMID: 30849190

5. Gage EA, Pailler M, and Zevon MA, et al (2011) Structuring survivorship care: discipline-specific clinician perspectives J Cancer Surviv 5(3) 217–225 https://doi.org/10.1007/s11764-011-0174-x PMID: 21311997 PMCID: 3123667

6. Oeffinger KC and McCabe MS (2006) Models for delivering survivorship care J Clin Oncol 24(32) 5117–5124 https://doi.org/10.1200/JCO.2006.07.0474 PMID: 17093273

7. Hudson SV, Chubak J, and Coups EJ, et al (2009) Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group Cancer Epidemiol Biomarkers Prev 18(7) 2152–2154 https://doi.org/10.1158/1055-9965.EPI-18-7-ASPO01 PMID: 19589917 PMCID: 4285698

8. Institute of Medicine and National Research Council (2006) From Cancer Patient to Cancer Survivor: Lost in Transition: An American Society of Clinical Oncology and Institute of Medicine Symposium (Washington, DC: The National Academies Press) [https://doi.org/10.17226/11613]

9. Rubinstein EB, Miller WL, and Hudson SV, et al (2017) Cancer survivorship care in advanced primary care practices: a qualitative study of challenges and opportunities JAMA Intern Med 177(12) 1726–1732 https://doi.org/10.1001/jamainternmed.2017.4747 PMID: 28973067 PMCID: 5820731

10. LaGrandeur W, Armin J, and Howe CL, et al (2018) Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: a scoping review J Cancer Surviv 12(3) 334–347 https://doi.org/10.1007/s11764-017-0673-5 PMID: 29332213

11. Powel LL and Seibert SM (2017) Cancer survivorship, models, and care plans: a status update Nurs Clin North Am 52(1) 193–209 https://doi.org/10.1016/j.cnur.2016.11.002 PMID: 28189163

12. Blanch-Hartigan D, Forsythe LP, and Alfano CM, et al (2014) Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians J Clin Oncol 32(15) 1578–1585 https://doi.org/10.1200/JCO.2013.51.7540 PMID: 24752057 PMCID: 4026581

13. Dossett LA, Hudson JN, and Morris AM, et al (2017) The primary care provider (PCP)-cancer specialist relationship: a systematic review and mixed-methods meta-synthesis CA Cancer J Clin 67(2) 156–169 https://doi.org/10.3322/caac.21385 PMCID: 5342924

14. Nekhlyudov L, O’Malley D M, and Hudson SV (2017) Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities Lancet Oncol 18(1) e30–e38 https://doi.org/10.1016/S1470-2045(16)30570-8 PMID: 28049575 PMCID: 5553291

15. Fayers PM (2001) Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30 Eur J Cancer 37(11) 1331–1334 https://doi.org/10.1016/S0959-8049(01)00127-7 PMID: 11435060

16. Nyarko E, Metz JM, and Nguyen GT, et al (2015) Cancer survivors’ perspectives on delivery of survivorship care by primary care physicians: an Internet-based survey BMC Fam Pract 16 143 https://doi.org/10.1186/s12875-015-0367-x

17. Giesinger JM, Kuijpers W, and Young T, et al (2016) Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain Health Qual Life Outcomes 14 87 https://doi.org/10.1186/s12955-016-0489-4 PMID: 27267486 PMCID: 4897949

18. Travis LB, Demark Wahnefried W, and Allan JM, et al (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors Nat Rev Clin Oncol 10(5) 289–301 https://doi.org/10.1038/nrclinonc.2013.41 PMID: 23529000

19. van de Poll-Franse LV, Nicolaije KAH, and Ezendam NPM (2017) The impact of cancer survivorship care plans on patient and health care provider outcomes: a current perspective Acta Oncol (Madr) 56(2) 134-138 https://doi.org/10.1080/0284186X.2016.1266080

20. Brothers BM, Easley A, and Salani R, et al (2013) Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients Gynecol Oncol 129(3) 554-558 https://doi.org/10.1016/j.ygyno.2013.02.037 PMCID: 3767310